Date:
September 10, 2024
Category:
SARS-CoV-2, influenza A+B and RSV antigen test (nasopharyngeal swab)
The Influenza A+B/RSV Ag Combination Rapid Test is very useful for rapid diagnosis of SARS-CoV-2, Influenza A, Influenza B and RSV infections. Early detection helps to ensure rapid treatment, prevent the spread of disease and effectively manage healthcare resources. It also helps to differentiate between similar respiratory infections and supports public health surveillance.
Contact our sales team for availability and delivery time
What is this test?
The combined rapid test from a nasopharyngeal swab detects SARS-CoV-2 (COVID-19), Influenza A, Influenza B, and RSV antigens. It assists emergency departments, pediatrics, and primary care in quickly identifying common seasonal viral pathogens and applying appropriate isolation measures.
Technical information
- Method
- Lateral flow chromatographic immunoassay
- Result in
- 15 min
- Storage temperature
- 2–30 °C
- Shelf life
- 24 months
- Sensitivity
- 97 %
- Specificity
- 99 %
- Accuracy
- 98 %
- Equipment
- Not required – visual reading
- Compliance
- CE-marked in vitro diagnostic device
Variants and order codes
| Code | Specimen | Format | Pack size |
|---|---|---|---|
| AF-CK2NFQ | Swab | Cassette | 20 tests |
Accuracy, sensitivity and specificity
| SARS-CoV-2 | Accuracy: 98.62 % | Sensitivity: 96.23 % | Specificity: 99.61 % |
| Influenza A | Accuracy: 98.07 % | Sensitivity: 94.83 % | Specificity: 98.68 % |
| Influenza B | Accuracy: 98.34 % | Sensitivity: 96.97 % | Specificity: 98.48 % |
| RSV | Accuracy: 98.90 % | Sensitivity: 98.23 % | Specificity: 99.20 % |